This episode of Motley Full Money is brought to you by TD Ameritrade,

whether you want to place a trade on Twitter or get market news from your smart

speaker, TD Ameritrade has everything you need to invest on your favorite

platforms and devices. See what's new at TD Ameritrade.com slash innovation.

Also brought to you this week by molecule, the world's first molecular

air purifier that reduces symptoms for allergy and asthma sufferers.

For $75 off your first order, visit molecule.com. That's M O L E K U L E dot com and use the promo code full.

Everybody needs money. That's why they call it money.

Now best thing in life, I'm free, but you can get them to the present.

From full global headquarters, this is Motley Full Money. It's the Motley Full

Money Radio show. I'm Chris and I'll join me in studio this week.

Senior analyst Jason Moser, Matt Argusinger and Ron Gross. He was always

gentlemen. Hey, we do. We've got the latest headlines from Wall Street,

best selling author Ashley Vance is our guest. And as always, we're giving

inside look at the stocks on our radar. But we begin this week with Till Ray,

the well known Canadian cannabis company that I've never heard of until this

week. It started the year with a market cap of around $2 billion. And Jason,

it's going to close this week with a market cap of just north of $12 billion.

I'm used to seeing this kind of exponential rise with technology companies.

What is going on with this kind of a stock? I'm not even used to seeing that kind

of rise with tech companies, at least not in the course of a week. And I think

that's what we're seeing more or less, but coming from someone me who supports

...